Barr Pharmaceuticals said its subsidiary Barr Laboratories received FDA approval for its application to manufacture and market a generic version of Pharmacia and Upjohns Dostinex (cabergoline) tablets, 0.5 mg.

The FDA has approved a new patch form of Novartis Alzheimers disease treatment Exelon (rivastigmine transdermal system), the drugmaker said Monday.

Roche said the FDA has approved a supplemental New Drug Application to market Tamiflu (oseltamivir phosphate) capsules in 30 mg and 45 mg doses.

The FDA today approved the first generic versions of Novartis Lamisil (terbinafine hydrochloride) tablets, used to treat nail fungus infection (onychomycosis).

Bradley Pharmaceuticals has announced the launch of Peranex HC Cream (hydrocortisone acetate 2% -- lidocaine HCl 2%) by the Companys Kenwood Therapeutics division.

Critical Therapeutics said the FDA has approved the companys New Drug Application (NDA) for twice-daily Zyflo CR (zileuton) extended-release tablets.

The FDA approved Torisel (temsirolimus) from Wyeth for treating a type of advanced kidney cancer, but analysts say its potential may be limited.

The Family Research Council and a coalition of medical and women’s groups have filed suit to overturn the FDA’s decision to approve Plan B for OTC sales. They say the FDA lacked authority to approve the application and did so in response to political pressure.

Ten priority drugs were approved in 2006, the FDA says, down five from 2005.